SIGNIFICANCE OF SIV CELL SPECIFICITY FOR AIDS DISEASE PROCESSES
SIGNIFICANCE OF SIV CELL SPECIFICITY FOR AIDS DISEASE PROCESSES
批准号:
6247195
负责人:
TOSHIAKI KODAMA
金额:
$18.46万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-05-01 至 1998-04-30
中文摘要
大量的研究有力地表明,病毒
英文摘要
A substantial number of studies strongly indicate that the viral
envelope gene (env) determines the cell specificity of HIV-1 and
suggest that the cell specificity of human immunodeficiency virus type
1 (HIV-1) is one of the keys to understanding the complex nature of
disease processes in AIDS. HIV-1, with its high replicative ability
for macrophages, may have an important role in the transmission and
persistence of HIV-1, and T-lymphocytes may be responsible for the
clinical manifestation of immunodeficiency. The molecular mechanisms
by which cell type-specific HIV-1 influences the disease course and
disease manifestation, however, remain to be elucidated.
We explored the significance of viral cell specificity for the
disease processes of AIDS using the simian immunodeficiency virus
(SIV)/rhesus macaque model system. An SIVmac155/TT variant with high
replicative and cytopathic ability for rhesus T-lymphocytes from the
lymph nodes of a rhesus macaque that died following infection with
cloned SIVmac239 was isolated. An SIVmac155/MT variant with high
replicative ability for macrophages from the lymph nodes of the same
individual was also isolated. Sequence analysis revealed variant
specific amino acid changes in the V1 to V2 and V3 regions of gp120.
Ev/T3 env recombinant containing the TT-derived gp120 sequences and
Ev/M3 env recombinant containing the MT-derived gp120 sequences
displayed strong replicative ability for T-lymphocytes and
macrophages, respectively. Sequence analysis revealed TT-type env
variant was specifically present in the lymph nodes, but MT type env
variants were present in the lymph nodes and brain of the animal.
These data suggest that the gp120 of SIV is not only important for
determining the cell specificity, but may also contribute to SIV
tissue localization in vivo.
The significance of gp120 sequences of SIV for viral pathogenicity
in vivo was examined by experimental inoculation of four rhesus
macaques with either Ev/T3 or SIVmac239. All macaques established
virus infection as determined by plasma SIV antigenemia and anti-SIV
antibody responses. Surprisingly, all four macaques infected by Ev/T3
displayed very rapid, severe and selective depletion of CD4+ T cells
in peripheral blood at 2 weeks post-inoculation. In contrast, no
macaques infected by SIVmac239 displayed CD4+ T cell depletion through
the course of infection. The CD4/CD8 ratio in lymph nodes was also
severely inverted in macaques infected with Ev/T3, but not SIVmac239.
These studies demonstrated that the high replicative and cytopathic
abilities of Ev/T3 in CD4+ T cells in vitro remarkably reflect the
potential of this cloned virus to induce CD4+ T cell depletion in
vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SIV CORECEPTOR USAGE DETERMINES CD4+ T CELL DEPLETION
-
批准号:6592292
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV
-
批准号:6592291
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2002
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV
-
批准号:6453667
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+ T CELL DEPLETION
-
批准号:6453668
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
Pathogenic Conversion of Attenuated SIV D nef
-
批准号:6632497
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
Pathogenic Conversion of Attenuated SIV D nef
-
批准号:6747336
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
Pathogenic Conversion of Attenuated SIV D nef
-
批准号:6408006
-
项目类别:
-
资助金额:$31.31万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
Pathogenic Conversion of Attenuated SIV D nef
-
批准号:6511643
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2001
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+ T CELL DEPLETION
-
批准号:6116114
-
项目类别:
-
资助金额:$14.76万
-
财政年份:1999
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV
-
批准号:6116113
-
项目类别:
-
资助金额:$14.76万
-
财政年份:1999
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIGNIFICANCE OF SIV CELL SPECIFICITY FOR AIDS DISEASE PROCESSES
-
批准号:6277345
-
项目类别:
-
资助金额:$18.45万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:6399607
-
项目类别:
-
资助金额:$26.46万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:2542928
-
项目类别:
-
资助金额:$24.96万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:2887674
-
项目类别:
-
资助金额:$25.71万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:6373779
-
项目类别:
-
资助金额:$27.28万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:6510794
-
项目类别:
-
资助金额:$28.02万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION
-
批准号:6170760
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGIONS OF SIV
-
批准号:6277346
-
项目类别:
-
资助金额:$18.45万
-
财政年份:1998
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR BASIS OF SIV NEUROPATHOGENESIS: HIV
-
批准号:6247194
-
项目类别:
-
资助金额:$18.46万
-
财政年份:1997
-
负责人:TOSHIAKI KODAMA
-
依托单位:
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV: AIDS
-
批准号:6247196
-
项目类别:
-
资助金额:$18.46万
-
财政年份:1997
-
负责人:TOSHIAKI KODAMA
-
依托单位:
海外基金